Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9512)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marinho RT, Barreira DP. Hepatitis C, stigma and cure. World J Gastroenterol 2013; 19(40): 6703-6709 [PMID: 24187444 DOI: 10.3748/wjg.v19.i40.6703] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i40/6703.htm |
| Number | Citing Articles |
| 1 |
Kate Seear. Addressing alcohol and other drug stigma: Where to next?. Drug and Alcohol Review 2020; 39(2): 109 doi: 10.1111/dar.13028
|
| 2 |
Nour Ayoub, Taha Hatab, Abdul Rahman Bizri. Challenges Facing Viral Hepatitis C Elimination in Lebanon. Pathogens 2023; 12(3): 432 doi: 10.3390/pathogens12030432
|
| 3 |
Reda Biomy, Mohamed Abdelshafy, Ahmed Abdelmonem, Hesham Abu-Elenin, George Ghaly. Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System. Clinical Medicine Insights: Cardiology 2017; 11: 117954681771320 doi: 10.1177/1179546817713204
|
| 4 |
Omar T. Sims, Pamela A. Melton, Shaonin Ji. A Descriptive Analysis of a Community Clinic Providing Hepatitis C Treatment to Poor and Uninsured Patients. Journal of Community Health 2018; 43(4): 725 doi: 10.1007/s10900-018-0476-2
|
| 5 |
T. L. Tergast, U. Protzer, S. Zeuzem, L. Heitmann, C. Sarrazin, M. Lehmann, P. Ingiliz, M. Cornberg, R. Zimmermann, M. G. Gerlich, P. Buggisch, B. Wiebner, H. Wedemeyer. Strategietreffen: Virushepatitis in Deutschland eliminieren – Was ist zu tun?. Zeitschrift für Gastroenterologie 2023; 61(02): 198 doi: 10.1055/a-1978-9021
|
| 6 |
Eric G Hilgenfeldt, Alex Schlachterman, Roberto J Firpi. Hepatitis C: Treatment of difficult to treat patients. World Journal of Hepatology 2015; 7(15): 1953-1963 doi: 10.4254/wjh.v7.i15.1953
|
| 7 |
Kim Macbeth, Katherine Davidson, Jessie Anderson. Treating hepatitis C in a dedicated GP practice for homeless patients: a multidisciplinary approach. Gastrointestinal Nursing 2018; 16(Sup10): S29 doi: 10.12968/gasn.2018.16.Sup10.S29
|
| 8 |
M. Elle Saine, Tyler M. Moore, Julia E. Szymczak, Laura P. Bamford, Frances K. Barg, Nandita Mitra, Jason Schnittker, John H. Holmes, Vincent Lo Re, Wen-Jun Tu. Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection. PLOS ONE 2020; 15(2): e0228471 doi: 10.1371/journal.pone.0228471
|
| 9 |
H. Wedemeyer, A. S. Duberg, M. Buti, W. M. Rosenberg, S. Frankova, G. Esmat, N. Örmeci, H. Van Vlierberghe, M. Gschwantler, U. Akarca, S. Aleman, İ. Balık, T. Berg, F. Bihl, M. Bilodeau, A. J. Blasco, C. E. Brandão Mello, P. Bruggmann, F. Calinas, J. L. Calleja, H. Cheinquer, P. B. Christensen, M. Clausen, H. S. M. Coelho, M. Cornberg, M. E. Cramp, G. J. Dore, W. Doss, M. H. El‐Sayed, G. Ergör, C. Estes, K. Falconer, J. Félix, M. L. G. Ferraz, P. R. Ferreira, J. García‐Samaniego, J. Gerstoft, J. A. Giria, F. L. Gonçales, M. Guimarães Pessôa, C. Hézode, S. J. Hindman, H. Hofer, P. Husa, R. Idilman, M. Kåberg, K. D. E. Kaita, A. Kautz, S. Kaymakoglu, M. Krajden, H. Krarup, W. Laleman, D. Lavanchy, P. Lázaro, R. T. Marinho, P. Marotta, S. Mauss, M. C. Mendes Correa, C. Moreno, B. Müllhaupt, R. P. Myers, V. Nemecek, A. L. H. Øvrehus, J. Parkes, K. M. Peltekian, A. Ramji, H. Razavi, N. Reis, S. K. Roberts, F. Roudot‐Thoraval, S. D. Ryder, R. Sarmento‐Castro, C. Sarrazin, D. Semela, M. Sherman, G. E. Shiha, J. Sperl, P. Stärkel, R. E. Stauber, A. J. Thompson, P. Urbanek, P. Van Damme, I. van Thiel, D. Vandijck, W. Vogel, I. Waked, N. Weis, J. Wiegand, A. Yosry, A. Zekry, F. Negro, W. Sievert, E. Gower. Strategies to manage hepatitis C virus (HCV) disease burden. Journal of Viral Hepatitis 2014; 21(s1): 60 doi: 10.1111/jvh.12249
|
| 10 |
Hoo-Jeung CHO, Euna PARK. Changes in Quality of Life of Chronic Hepatitis C Patients Participating in Clinical Trial. JOURNAL OF FISHRIES AND MARINE SCIENCES EDUCATION 2018; 30(5): 1725 doi: 10.13000/JFMSE.2018.10.30.5.1725
|
| 11 |
Cristina Reygosa, Dalia Morales-Arraez, Alberto Hernández-Bustabad, Lorelay Melián Baute, Manuel Hernández-Guerra. Hepatitis C-treated patients as a potential source for referral of new cases. Gastroenterología y Hepatología (English Edition) 2021; 44(10): 704 doi: 10.1016/j.gastre.2021.03.004
|
| 12 |
Davoud Pourmarzi, Lisa Hall, Tony Rahman, David Lim, Gerard FitzGerald. Clinical effectiveness, cost-effectiveness and acceptability of community-based management of chronic hepatitis C: a mixed methods systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 2017; 15(4): 914 doi: 10.11124/JBISRIR-2016-003103
|
| 13 |
Maria Isis Freire de Aguiar, Naiana Pacífico Alves, Violante Augusta Batista Braga, Ângela Maria Alves e Souza, Michell Ângelo Marques Araújo, Paulo César de Almeida. ASPECTOS PSICOSSOCIAIS DA QUALIDADE DE VIDA DE RECEPTORES DE TRANSPLANTE HEPÁTICO. Texto & Contexto - Enfermagem 2018; 27(2) doi: 10.1590/0104-070720180003730016
|
| 14 |
Peter Hauser, Shira Kern. Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications. World Journal of Hepatology 2015; 7(15): 1921-1935 doi: 10.4254/wjh.v7.i15.1921
|
| 15 |
Rob Bielen, Christophe Moreno, Hans Van Vlierberghe, Stefan Bourgeois, Jean-Pierre Mulkay, Thomas Vanwolleghem, Wim Verlinden, Christian Brixko, Jochen Decaestecker, Chantal De Galocsy, Filip Janssens, Mike Cool, Lode Van Overbeke, Christophe Van Steenkiste, François D'heygere, Wilfried Cools, Frederik Nevens, Geert Robaeys. Belgian experience with direct acting antivirals in people who inject drugs. Drug and Alcohol Dependence 2017; 177: 214 doi: 10.1016/j.drugalcdep.2017.04.003
|
| 16 |
Andrew H. Talal, Urmo Jaanimägi, Arpan Dharia, Suzanne S. Dickerson. Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder. Health Expectations 2023; 26(6): 2594 doi: 10.1111/hex.13854
|
| 17 |
Emil Chiauzzi, Pronabesh DasMahapatra, Elisenda Cochin, Mikele Bunce, Raya Khoury, Purav Dave. Factors in Patient Empowerment: A Survey of an Online Patient Research Network. The Patient - Patient-Centered Outcomes Research 2016; 9(6): 511 doi: 10.1007/s40271-016-0171-2
|
| 18 |
Stefan Zeuzem, Ira M. Jacobson, Tolga Baykal, Rui T. Marinho, Fred Poordad, Marc Bourlière, Mark S. Sulkowski, Heiner Wedemeyer, Edward Tam, Paul Desmond, Donald M. Jensen, Adrian M. Di Bisceglie, Peter Varunok, Tarek Hassanein, Junyuan Xiong, Tami Pilot-Matias, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki, Barry Bernstein. Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin. New England Journal of Medicine 2014; 370(17): 1604 doi: 10.1056/NEJMoa1401561
|
| 19 |
Hoo Jeung Cho, Euna Park. Quality of Life of Chronic Hepatitis C Patients and Its Associated Factors. Osong Public Health and Research Perspectives 2017; 8(2): 124 doi: 10.24171/j.phrp.2017.8.2.04
|
| 20 |
Hilary L. Surratt, Janet K. Otachi, Christopher J. McLouth, Nikita Vundi. Healthcare stigma and HIV risk among rural people who inject drugs. Drug and Alcohol Dependence 2021; 226: 108878 doi: 10.1016/j.drugalcdep.2021.108878
|
| 21 |
Eduardo Mastrangelo Marinho Falcão, Beatriz Moritz Trope, Mariana Marteleto Godinho, Leonardo Hoehl Carneiro, João Marcello de Araujo-Neto, Cristiane Alves Villela Nogueira, Marcia Ramos-e-Silva. Cutaneous Eruption due to Telaprevir. Case Reports in Dermatology 2015; 7(3): 253 doi: 10.1159/000439264
|
| 22 |
Peter Hauser. Hepatitis C and Psychiatric and Substance Use Disorders Co-morbidities; Caring for People with Hepatitis C: Lessons from the Past that Inform Expectations in the Future. Open Medicine Journal 2016; 3(1): 49 doi: 10.2174/1874220301603010049
|
| 23 |
Luis A Gonzalez Corro, Katie Zook, Miles Landry, Amanda Rosecrans, Robert Harris, Darrell Gaskin, Oluwaseun Falade-Nwulia, Kathleen R Page, Gregory M Lucas. An Analysis of Social Determinants of Health and Their Implications for Hepatitis C Virus Treatment in People Who Inject Drugs: The Case of Baltimore. Open Forum Infectious Diseases 2024; 11(4) doi: 10.1093/ofid/ofae107
|
| 24 |
Amaravadhi Harikishore, Enlin Li, Jia Jun Lee, Nam-Joon Cho, Ho Sup Yoon. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase. Molecular Diversity 2015; 19(3): 529 doi: 10.1007/s11030-015-9591-5
|
| 25 |
Amine Bout, Chadya Aarab, Khadija Ayoubi, Rachid Aalouane, Ismail Rammouz. Les troubles anxio-dépressifs chez des patients porteurs du virus de l’hépatite C au moment de la cure par interféron : une étude longitudinale. Annales Médico-psychologiques, revue psychiatrique 2019; 177(1): 45 doi: 10.1016/j.amp.2017.03.033
|
| 26 |
Leyla de Avila, Ali A. Weinstein, J. Michael Estep, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M. Younossi. Cytokine balance is restored as patient‐reported outcomes improve in patients recovering from chronic hepatitis C. Liver International 2019; 39(9): 1631 doi: 10.1111/liv.14115
|
| 27 |
Omar T. Sims, Jhumka Gupta, Stacey A. Missmer, Irene O. Aninye. Stigma and Endometriosis: A Brief Overview and Recommendations to Improve Psychosocial Well-Being and Diagnostic Delay. International Journal of Environmental Research and Public Health 2021; 18(15): 8210 doi: 10.3390/ijerph18158210
|
| 28 |
Marianthi Markatou, Oliver Kennedy, Michael Brachmann, Raktim Mukhopadhyay, Arpan Dharia, Andrew H. Talal. Social determinants of health derived from people with opioid use disorder: Improving data collection, integration and use with cross-domain collaboration and reproducible, data-centric, notebook-style workflows. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1076794
|
| 29 |
Christiana Graf, Christoph Sarrazin. Stand der nationalen und globalen Hepatitis-C-Elimination. Die Innere Medizin 2024; doi: 10.1007/s00108-024-01684-5
|
| 30 |
Elena M. Wojcik, Melinda J. Sharon, Stephen M. Davis, Owen M. Lander, Carmen N. Burrell, Kabir Yadav. Centers for Disease Control and Prevention Recommendations for Hepatitis C Testing: The Need to Adopt Universal Screening in an Appalachian Emergency Department. Academic Emergency Medicine 2020; 27(9): 844 doi: 10.1111/acem.13932
|
| 31 |
Zhicheng Wang, Quinn Grundy, Lisa Parker, Lisa Bero. Health promoter, advocate, legitimiser — the many roles of WHO guidelines: a qualitative study. Health Research Policy and Systems 2019; 17(1) doi: 10.1186/s12961-019-0489-z
|
| 32 |
Elisabetta Teti. Hepatitis C management and treatment among people who inject drugs in Italy: an exploratory pilot survey.. MISSION 2020; (54) doi: 10.3280/mis54-2020oa9744
|
| 33 |
Wilson Ly, Jennifer Cocohoba, Alexander Chyorny, Jodi Halpern, Colette Auerswald, Janet Myers. Perspectives on Integrated HIV and Hepatitis C Virus Testing Among Persons Entering a Northern California Jail: A Pilot Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 2018; 78(2): 214 doi: 10.1097/QAI.0000000000001664
|
| 34 |
Taruja Karmarkar, Carla V. Rodriguez-Watson, Eric Watson, Hanke Zheng, Darrell J. Gaskin, William V. Padula. Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis. Value in Health 2022; 25(9): 1499 doi: 10.1016/j.jval.2022.03.003
|
| 35 |
Elahe Bijari, Masood Ziaee, Gholamreza Sharifzadeh. Stigmatization of Hepatitis C by Medical Sciences Students and Healthcare Providers: A Descriptive-Analytical Epidemiological Study. Modern Care Journal 2017; 14(3) doi: 10.5812/modernc.65822
|
| 36 |
D. A. Lioznov, N. V. Dunaeva, N. H. Chung, O. V. Gorchakova, T. V. Antonova. Chronic hepatitis C: modern condition of the problem. Nephrology (Saint-Petersburg) 2019; 23(4): 36 doi: 10.24884/1561-6274-2019-23-4-36-46
|
| 37 |
Oluwaseun Falade‐Nwulia, Rachel E. Gicquelais, Jacquie Astemborski, Sean D. McCormick, Greg Kirk, Mark Sulkowski, David L. Thomas, Shruti H. Mehta. Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era. Liver International 2020; 40(10): 2407 doi: 10.1111/liv.14634
|
| 38 |
Erika F Duffell, Dagmar Hedrich, Otilia Mardh, Antons Mozalevskis. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions.
Eurosurveillance 2017; 22(9) doi: 10.2807/1560-7917.ES.2017.22.9.30476
|
| 39 |
David Pires Barreira, Rui Tato Marinho, Manuel Bicho, Renata Fialho, Silvia Raquel Soares Ouakinin. Psychosocial and Neurocognitive Factors Associated With Hepatitis C – Implications for Future Health and Wellbeing. Frontiers in Psychology 2019; 9 doi: 10.3389/fpsyg.2018.02666
|
| 40 |
Noel Tsui, Gabriel B. Tjong, Abigail J. Simms, Sarah A. Edwards, Shelley Cripps. Hepatitis C (HCV) prevalence in citizens of the Métis Nation of Ontario. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09171-w
|
| 41 |
Lijie Yu, Jian Wang, Dawei Zhu, Anli Leng, Knut R Wangen. Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China. Human Vaccines & Immunotherapeutics 2016; 12(1): 70 doi: 10.1080/21645515.2015.1069932
|
| 42 |
Kate Seear, Suzanne Fraser, Sean Mulcahy, Dion Kagan, Emily Lenton, Adrian Farrugia, kylie valentine. Echoes and Antibodies: Legal Veridiction and the Emergence of the Perpetual Hepatitis C Subject. Social & Legal Studies 2023; 32(2): 216 doi: 10.1177/09646639221115698
|
| 43 |
Davoud Pourmarzi, Lisa Hall, Andrew Smirnov, Julie Hepworth, Tony Rahman, Gerard FitzGerald. Framework for community-based models for treating hepatitis C virus. Australian Health Review 2020; 44(3): 459 doi: 10.1071/AH18220
|
| 44 |
Diogo Libânio, Rui Tato Marinho. Impact of hepatitis C oral therapy in portal hypertension. World Journal of Gastroenterology 2017; 23(26): 4669-4674 doi: 10.3748/wjg.v23.i26.4669
|
| 45 |
Andrew H. Talal, Urmo Jaanimägi, Kathleen Davis, Jordan Bailey, Barbara M. Bauer, Arpan Dharia, Saliyah George, Anthony McLeod, Karen Morton, Ann Nugent, Marija Zeremski, Amreen Dinani, Don C. Des Jarlais, Ponni V. Perumalswami, Jonathan N. Tobin, Suzanne S. Dickerson. Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers. Journal of Substance Abuse Treatment 2021; 127: 108421 doi: 10.1016/j.jsat.2021.108421
|
| 46 |
Rui Tato Marinho, António Costa, Teodomiro Pires, Helena Raposo, Carlos Vasconcelos, Cristina Polónia, Joaquim Borges, Mariana Soares, Graça Vilar, Ana Maria Nogueira. A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1883-6
|
| 47 |
Hye Won Lee, Myunghwa Kim, Jin Youn, Shikha Singh, Sang Hoon Ahn. Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors. Yonsei Medical Journal 2022; 63(12): 1088 doi: 10.3349/ymj.2022.0332
|
| 48 |
Lucas Wiessing, Marica Ferri, Bart Grady, Maria Kantzanou, Ida Sperle, Katelyn J. Cullen, Angelos Hatzakis, Maria Prins, Peter Vickerman, Jeffrey V. Lazarus, Vivian D. Hope, Catharina Matheï, Yury E. Khudyakov. Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention. PLoS ONE 2014; 9(7): e103345 doi: 10.1371/journal.pone.0103345
|
| 49 |
Omar T. Sims, Quentin R. Maynard, Pam A. Melton. Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review. Social Work in Public Health 2016; 31(6): 565 doi: 10.1080/19371918.2016.1160346
|
| 50 |
Yousra A Mohamoud, F DeWolfe Miller, Laith J Abu-Raddad. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker. World Journal of Gastroenterology 2014; 20(36): 12734-12752 doi: 10.3748/wjg.v20.i36.12734
|
| 51 |
A.W. Batchelder, D. Peyser, S. Nahvi, J.H. Arnsten, A.H. Litwin. “Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment. Drug and Alcohol Dependence 2015; 153: 66 doi: 10.1016/j.drugalcdep.2015.06.007
|
| 52 |
X. Li, N. S. Chan, A. W. Tam, I. F. N. Hung, E. W. Chan. Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(10): 1801 doi: 10.1007/s10096-017-2995-7
|
| 53 |
Daniele Blasquez Olmedo, Patrícia Marraccini Precioso, António Lugdero-Correia, Guida da Silva, Angela Maria Guimarães dos Santos, Luís Cristóvão Pôrto. Exposure source prevalence is associated with gender in hepatitis C virus patients from Rio de Janeiro, Brazil. Memórias do Instituto Oswaldo Cruz 2017; 112(9): 632 doi: 10.1590/0074-02760160553
|
| 54 |
Timothy A. Bach, Kathy Zaiken. Real-World Drug Costs of Treating Hepatitis C Genotypes 1-4 with Direct-Acting Antivirals: Initiating Treatment at Fibrosis 0-2 and 3-4. Journal of Managed Care & Specialty Pharmacy 2016; 22(12): 1437 doi: 10.18553/jmcp.2016.22.12.1437
|
| 55 |
Nicolae-Catalin Mechie, Christian Röver, Silke Cameron, Ahmad Amanzada. Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis. World Journal of Hepatology 2014; 6(10): 759-765 doi: 10.4254/wjh.v6.i10.759
|
| 56 |
Ellen Childs, Sabrina A. Assoumou, Katie B. Biello, Dea L. Biancarelli, Mari-Lynn Drainoni, Alberto Edeza, Peter Salhaney, Matthew J. Mimiaga, Angela R. Bazzi. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduction Journal 2019; 16(1) doi: 10.1186/s12954-019-0286-6
|
| 57 |
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life. Minerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
|
| 58 |
E. Whitney Simpson, Omar T. Sims, Carol S. North, Barry A. Hong, David E. Pollio. Family Psychoeducation for Hepatitis C Patients and Their Families: Recommendation for Clinicians. Social Work with Groups 2017; 40(3): 202 doi: 10.1080/01609513.2016.1149545
|
| 59 |
Qudrat Ullah, Asad Ullah, Younas Khan, Farooq Ahmad Khan, Sajid Ali. THE EXTENT OF PREVAILING STIGMA AMONG HEPATITIS C PATIENTS IN PESHAWAR KHYBER PUKHTUNKHWA PAKISTAN. Humanities & Social Sciences Reviews 2021; 9(3): 1595 doi: 10.18510/hssr.2021.93160
|
| 60 |
Andrew Talal, Urmo Jaanimägi, Arpan Dharia, Suzanne S. Dickerson. Mitigating the Stigma of Addiction and Hepatitis C Virus Via Patient-Centered Telemedicine to Improve Whole-Person Care. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4054245
|
| 61 |
Deane E. Smith, Stacey Chen, Anthony Fargnoli, Tyler Lewis, Aubrey C. Galloway, Zachary N. Kon, Nader Moazami. Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors. Seminars in Thoracic and Cardiovascular Surgery 2021; 33(2): 407 doi: 10.1053/j.semtcvs.2020.06.045
|
| 62 |
Maria de Lourdes Albuquerque de QUEIROGA, Raymundo PARANÁ, José Eymard Moraes de MEDEIROS FILHO, Giovannini Cesar A FIGUEIREDO, Ananda Peixoto de ARAÚJO, Hagley Walson Soares LEITE, Itiel de Souza AQUINO, Leonardo Honório de A MELO NETO. GAMMA GLUTAMYLTRANSFERASE IMPACT IN THERAPEUTIC RESPONSE OF CHRONIC HEPATITIS C: a systematic review of the literature. Arquivos de Gastroenterologia 2015; 52(3): 239 doi: 10.1590/S0004-28032015000300016
|
| 63 |
Irene Pericot-Valverde, Moonseong Heo, Jiajing Niu, Lior Rennert, Brianna L. Norton, Matthew J. Akiyama, Julia Arnsten, Alain H. Litwin. Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder. Drug and Alcohol Dependence 2022; 234: 109403 doi: 10.1016/j.drugalcdep.2022.109403
|
| 64 |
Sarah Bauerle Bass, Amy Jessop, Laurie Maurer, Muhamed Gashat, Mohammed Al Hajji, Mercedes Gutierrez. Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development. Journal of Health Communication 2018; 23(1): 117 doi: 10.1080/10810730.2017.1414902
|
| 65 |
Cristina Reygosa, Dalia Morales-Arraez, Alberto Hernández-Bustabad, Lorelay Melián Baute, Manuel Hernández-Guerra. El paciente tratado de hepatitis C como fuente potencial de derivación de nuevos casos. Gastroenterología y Hepatología 2021; 44(10): 704 doi: 10.1016/j.gastrohep.2021.03.006
|
| 66 |
Benedikte Bjøro, Olav Dalgard, Håvard Midgard, Hans Verbaan, Milada Cvancarova Småstuen, Tone Rustøen. Increased hope following successful treatment for hepatitis C infection. Journal of Advanced Nursing 2018; 74(3): 724 doi: 10.1111/jan.13487
|
| 67 |
J. Anjo, A. Café, A. Carvalho, M. Doroana, J. Fraga, J. Gíria, R. Marinho, S. Santos, J. Velosa. O impacto da hepatite C em Portugal. GE Jornal Português de Gastrenterologia 2014; 21(2): 44 doi: 10.1016/j.jpg.2014.03.001
|
| 68 |
Anli Leng, Youwei Li, Knut Reidar Wangen, Stephen Nicholas, Elizabeth Maitland, Jian Wang. Hepatitis B discrimination in everyday life by rural migrant workers in Beijing. Human Vaccines & Immunotherapeutics 2016; 12(5): 1164 doi: 10.1080/21645515.2015.1131883
|
| 69 |
M. Elle Saine, Julia E. Szymczak, Tyler M. Moore, Laura P. Bamford, Frances K. Barg, Jason Schnittker, John H. Holmes, Nandita Mitra, Vincent Lo Re. Determinants of stigma among patients with hepatitis C virus infection. Journal of Viral Hepatitis 2020; 27(11): 1179 doi: 10.1111/jvh.13343
|